In-situ Clinical Trial Assessing Ability to Detect and Monitor Active Caries and Their Remineralization
NCT ID: NCT07100626
Last Updated: 2026-01-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
12 participants
INTERVENTIONAL
2025-09-24
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Can BlueCheck® reliably detect early carious lesions with high sensitivity and specificity?
* Does BlueCheck® visually reflect changes in remineralized enamel lesions?
BlueCheck® results will be compared against standard diagnostic methods (e.g., Nyvad criteria, Diagnodent readings, surface microhardness) to see if BlueCheck® provides an objective, accurate, and visual method of detecting and monitoring early-stage caries.
Participants will:
* Wear a modified lower partial denture with four mounted enamel specimens for 28 days.
* Use only the study-provided fluoride containing toothpaste
* Attend weekly clinic visits for removal and laboratory analysis of one enamel specimen per week.
* Undergo regular oral health checks and provide diary entries tracking brushing and any adverse events.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Radiation-Free Caries Detection Integrated Into Intraoral Scanners Compared With Conventional Diagnostic Methods
NCT07342595
Dentine Tubule Occlusion Assessment in a Modified in Situ Model
NCT02768194
Surface Caries Feature Study
NCT07048444
Evaluation of Esthetic Performance of Resin Infiltration Technique on Enamel Lesions
NCT02896556
Intra Oral Scan and CBCT Aided Diagnosis of Dental Plaque and Caries
NCT06945354
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
TRIPLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BlueCheck
Caries Detection and Monitoring
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* be between 18 and 85 years old;
* understand and be willing, able and likely to comply with all study procedures and restrictions;
* be wearing a removable mandibular partial denture with sufficient room to accommodate four (4) human enamel specimens (4 mm round) in their partial denture on both sides (two specimens on each side, bilateral partial denture) or one side (4 specimens on one side, unilateral partial denture)
* be willing and capable of wearing their removable partial denture 24 hours a day for four (4), one-week treatment periods, maximum total duration four (4) weeks;
* be willing to allow study personnel to drill specimen sites in the posterior section of one or both sides of their lower partial denture (teeth and/or buccal flange area below the teeth); and
* be in good medical and dental health with no active caries or periodontal disease.
* have a salivary flow rate in the range of normal values (unstimulated whole saliva flow rate ≥ 0.2 mL/min; gum base stimulated whole saliva flow rate ≥ 0.8 mL/min).
Exclusion Criteria
* currently have any medical condition that could be expected to interfere with the subject's safety during the study period;
* currently be taking antibiotics or have taken antibiotics in the two weeks prior to the beginning treatment;
* known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients;
* have participated in another clinical study or receipt of an investigational drug within 30 days of beginning treatment; or
* be taking fluoride supplements, required to use a fluoride mouthrinse or have received a professional fluoride treatment in the two weeks preceding specimen placement.
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oral Health Research Institute, Indiana University School of Dentistry
UNKNOWN
Incisive Technologies Pty Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frank Lippert, PhD
Role: PRINCIPAL_INVESTIGATOR
Oral Health Research Institute, Indiana University School of Dentistry
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oral Health Research Institute
Indianapolis, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
25-I-126
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.